Surgery Partners, Inc. (SGRY) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
58/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinSGRY / S&P 40.94% / 15.20% |
LoseSGRY / S&P 3.99% / 15.00% |
LoseSGRY / S&P -51.75% / 50.40% |
| 2026-Q10/3 |
LoseSGRY / S&P -22.85% / -4.33% |
LoseSGRY / S&P 5.38% / 11.30% |
LoseSGRY / S&P -61.44% / 27.70% |
| 2025-Q40/3 |
LoseSGRY / S&P -28.60% / 2.65% |
LoseSGRY / S&P 6.24% / 9.00% |
LoseSGRY / S&P -54.14% / 13.40% |
| 2025-Q32/3 |
LoseSGRY / S&P -2.65% / 8.12% |
WinSGRY / S&P 10.14% / 4.61% |
WinSGRY / S&P 189.36% / 13.45% |
| 2025-Q22/3 |
LoseSGRY / S&P -6.40% / 10.94% |
WinSGRY / S&P 12.05% / 4.83% |
WinSGRY / S&P 450.00% / 10.63% |
| 2025-Q12/3 |
WinSGRY / S&P 12.19% / -4.27% |
WinSGRY / S&P 13.54% / 4.98% |
LoseSGRY / S&P -15400.00% / 10.57% |
| 2024-Q42/3 |
LoseSGRY / S&P -34.34% / 2.41% |
WinSGRY / S&P 13.52% / 5.25% |
WinSGRY / S&P 1377.78% / 6.15% |
| 2024-Q33/3 |
WinSGRY / S&P 35.52% / 5.89% |
WinSGRY / S&P 9.96% / 5.89% |
WinSGRY / S&P 42.42% / 6.11% |
| 2024-Q21/3 |
LoseSGRY / S&P -20.25% / 4.28% |
WinSGRY / S&P 8.55% / 5.38% |
LoseSGRY / S&P -54.39% / 5.12% |
| 2024-Q11/3 |
LoseSGRY / S&P -6.75% / 10.56% |
WinSGRY / S&P 7.10% / 5.71% |
LoseSGRY / S&P -101.08% / 5.59% |
| 2023-Q41/3 |
LoseSGRY / S&P 9.37% / 11.69% |
WinSGRY / S&P 8.03% / 6.81% |
LoseSGRY / S&P -84.75% / 7.78% |
| 2023-Q32/3 |
LoseSGRY / S&P -34.99% / -3.27% |
WinSGRY / S&P 11.16% / 7.52% |
WinSGRY / S&P 17.86% / -5.03% |
| 2023-Q23/3 |
WinSGRY / S&P 30.52% / 8.74% |
WinSGRY / S&P 11.78% / 9.50% |
WinSGRY / S&P 103.57% / -8.57% |
| 2023-Q13/3 |
WinSGRY / S&P 23.73% / 7.50% |
WinSGRY / S&P 13.01% / 10.77% |
WinSGRY / S&P 102.17% / -15.69% |
| 2022-Q42/3 |
WinSGRY / S&P 19.06% / 7.56% |
WinSGRY / S&P 14.12% / 11.88% |
LoseSGRY / S&P -49.57% / -17.99% |
| 2022-Q30/3 |
LoseSGRY / S&P -19.09% / -4.88% |
LoseSGRY / S&P 12.91% / 13.47% |
LoseSGRY / S&P -79.10% / -1.41% |
| 2022-Q20/3 |
LoseSGRY / S&P -47.47% / -16.10% |
LoseSGRY / S&P 13.38% / 13.71% |
LoseSGRY / S&P -88.89% / 11.04% |
| 2022-Q12/3 |
WinSGRY / S&P 3.07% / -4.60% |
WinSGRY / S&P 19.54% / 15.97% |
LoseSGRY / S&P -84.62% / 42.23% |
| 2021-Q42/3 |
WinSGRY / S&P 26.15% / 11.03% |
WinSGRY / S&P 19.62% / 15.00% |
LoseSGRY / S&P -63.21% / 96.40% |
| 2021-Q31/3 |
LoseSGRY / S&P -36.45% / 0.58% |
WinSGRY / S&P 18.27% / 10.77% |
LoseSGRY / S&P -63.49% / 69.42% |
| 2021-Q22/3 |
WinSGRY / S&P 50.52% / 8.55% |
WinSGRY / S&P 17.66% / 6.58% |
LoseSGRY / S&P -7.35% / 51.81% |
| 2021-Q13/3 |
WinSGRY / S&P 52.57% / 6.17% |
WinSGRY / S&P 4.09% / -1.06% |
WinSGRY / S&P 22.04% / 7.39% |
| 2020-Q43/3 |
WinSGRY / S&P 32.47% / 12.15% |
WinSGRY / S&P 1.57% / -3.72% |
WinSGRY / S&P 38.86% / -33.42% |
| 2020-Q33/3 |
WinSGRY / S&P 89.28% / 8.93% |
WinSGRY / S&P 1.31% / -2.04% |
WinSGRY / S&P -25.86% / -27.10% |
| 2020-Q22/3 |
WinSGRY / S&P 77.18% / 20.54% |
WinSGRY / S&P -0.05% / -0.46% |
LoseSGRY / S&P -46.14% / -27.11% |
| 2020-Q11/3 |
LoseSGRY / S&P -58.29% / -19.60% |
WinSGRY / S&P 4.42% / 3.47% |
LoseSGRY / S&P -51.29% / -14.75% |
| 2019-Q41/3 |
WinSGRY / S&P 111.98% / 9.07% |
LoseSGRY / S&P 3.38% / 5.36% |
LoseSGRY / S&P -53.83% / 2.99% |
| 2019-Q30/3 |
LoseSGRY / S&P -9.28% / 1.70% |
LoseSGRY / S&P SGRY unavailable / 5.02% |
LoseSGRY / S&P SGRY unavailable / 0.21% |
| 2019-Q20/3 |
LoseSGRY / S&P -27.84% / 4.30% |
LoseSGRY / S&P SGRY unavailable / 6.64% |
LoseSGRY / S&P SGRY unavailable / 8.65% |
| 2019-Q11/3 |
WinSGRY / S&P 15.22% / 13.65% |
LoseSGRY / S&P SGRY unavailable / 8.12% |
LoseSGRY / S&P SGRY unavailable / 14.29% |
| 2018-Q40/3 |
LoseSGRY / S&P -40.67% / -13.52% |
LoseSGRY / S&P SGRY unavailable / 9.05% |
LoseSGRY / S&P SGRY unavailable / 18.23% |
| 2018-Q31/3 |
WinSGRY / S&P 10.74% / 7.71% |
LoseSGRY / S&P SGRY unavailable / 10.21% |
LoseSGRY / S&P SGRY unavailable / 19.06% |
| 2018-Q20/3 |
LoseSGRY / S&P -13.12% / 3.43% |
LoseSGRY / S&P SGRY unavailable / 9.03% |
LoseSGRY / S&P SGRY unavailable / 14.46% |
| 2018-Q11/3 |
WinSGRY / S&P 41.74% / -0.76% |
LoseSGRY / S&P SGRY unavailable / 7.68% |
LoseSGRY / S&P SGRY unavailable / 12.46% |
| 2017-Q41/3 |
WinSGRY / S&P 16.91% / 6.64% |
LoseSGRY / S&P SGRY unavailable / 7.03% |
LoseSGRY / S&P SGRY unavailable / 13.82% |
| 2017-Q30/3 |
LoseSGRY / S&P -54.51% / 4.48% |
LoseSGRY / S&P SGRY unavailable / 5.68% |
LoseSGRY / S&P SGRY unavailable / 17.57% |
| 2017-Q22/3 |
WinSGRY / S&P 16.67% / 3.09% |
WinSGRY / S&P 9.77% / 4.83% |
LoseSGRY / S&P -51.61% / 17.74% |
| 2017-Q13/3 |
WinSGRY / S&P 23.03% / 6.07% |
WinSGRY / S&P 16.13% / 3.67% |
WinSGRY / S&P 180.00% / 13.32% |
| 2016-Q42/3 |
LoseSGRY / S&P -21.69% / 3.82% |
WinSGRY / S&P 19.33% / 2.09% |
WinSGRY / S&P 375.00% / 7.05% |
| 2016-Q32/3 |
WinSGRY / S&P 13.07% / 3.85% |
WinSGRY / S&P 25.85% / 0.20% |
LoseSGRY / S&P -116.74% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | SGRY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -38.61% | 20.78% |
| Annualized return | -38.61% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | SGRY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -72.31% | 83.14% |
| Annualized return | -22.65% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | SGRY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -27.18% | 319.30% |
| Annualized return | -3.12% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ardent Health, Inc. (ARDT) | United States | $1.478B | 17.91 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |
| TENET HEALTHCARE CORP (THC) | United States | $20.097B | |
| HCA Healthcare, Inc. (HCA) | United States | $93.934B | 15.49 |